ChromoQuant^® QF-PCR kits are a family of products for fast diagnosis of the most common chromosomal disorders in foetuses. ChromoQuant^® detects Trisomy 21 (Down syndrome), Trisomy 13 (Patau syndrome), Trisomy 18 (Edwards syndrome) and aneuploidies in the sex chromosomes X and Y, i.e. Klinefelter syndrome and Turner syndrome. Download brochure.

 

The tests have been clinically validated for In Vitro Diagnostics and are CE marked.

• The diagnostic procedure is based upon amniocentesis. Results are achieved within 6 hours enabling a "time to reply" of 24 hours
• The ChromoQuant^® kit is tested and available for all ABI and MegaBACE sequencers. Diagnostic procedures based on ChromoQuant® can be automated for cost efficient high throughput analysis.
• ChromoQuant® is CE marked for IVD use and produced according to ISO13485-2003 and ISO 9001-2000. 
• Fast data evaluation is facilitated by the proprietary ChromoQuant^® Visualizer software licensed to all users.

ChromoQuant^® has been thoroughly validated. It was Iinitially as part of a joint study together with the department of clinical genetics at the Karolinska HospitalKarolinska Hospital in Stockholm, Sweden (2002-2004).

 

ChromoQuant^® was clinically introduced in early 2004 and is used world wide. More than 44.000 clinical tests have been performed with the ChromoQuant test since 2004 (october 2009).

 

Contact CyberGene AB for information about prices. Contact your local distributor.